YAP-dependent proliferation by a small molecule targeting annexin A2

Sophia Z Shalhout1,2,3, Peng-Yu Yang4,5, Edyta M Grzelak4

  • 1Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.

Insights

Researchers discovered PY-60, a small molecule that activates Yes-associated protein (YAP) transcriptional activity. This molecule promotes skin cell regeneration and reveals annexin A2 as a potential therapeutic target for regenerative medicine.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Regenerative Medicine

Background:

  • The transcriptional coactivator Yes-associated protein (YAP) regulates cell proliferation and tissue regeneration.
  • Activating YAP holds therapeutic potential for diseases with impaired regenerative repair.

Purpose of the Study:

  • To identify small molecules that activate YAP transcriptional activity.
  • To elucidate the mechanism of YAP activation and its therapeutic implications.

Main Methods:

  • In vitro assays to measure YAP transcriptional activity.
  • Topical drug administration in mice to assess epidermal keratinocyte expansion.
  • Chemical proteomics to identify the molecular target of the small molecule.

Main Results:

  • Discovery of PY-60, a small molecule that robustly activates YAP.
  • PY-60 promotes YAP-dependent epidermal keratinocyte expansion in mice.
  • Annexin A2 (ANXA2) identified as the direct target of PY-60.
  • PY-60 treatment causes ANXA2 release from the cell membrane, activating YAP.

Conclusions:

  • Annexin A2 is a novel, druggable component of the Hippo pathway.
  • PY-60 activates YAP by modulating ANXA2.
  • This study provides a mechanistic basis for promoting regenerative repair through YAP activation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K